These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8072436)

  • 1. Alzheimer disease: an imbalance of proteolytic regulation?
    Smith MA; Perry G
    Med Hypotheses; 1994 Apr; 42(4):277-9. PubMed ID: 8072436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuritic plaques in Alzheimer disease originate from neurofibrillary tangles.
    Perry G
    Med Hypotheses; 1993 Apr; 40(4):257-8. PubMed ID: 8321160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striation is the characteristic neuritic abnormality in Alzheimer disease.
    Velasco ME; Smith MA; Siedlak SL; Nunomura A; Perry G
    Brain Res; 1998 Dec; 813(2):329-33. PubMed ID: 9838181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
    Yilmazer-Hanke DM; Hanke J
    Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophic neurites define diffuse as well as core-containing senile plaques in Alzheimer's disease.
    Rifenburg RP; Perry G
    Neurodegeneration; 1995 Jun; 4(2):235-7. PubMed ID: 7583689
    [No Abstract]   [Full Text] [Related]  

  • 6. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
    Thal DR; Härtig W; Schober R
    J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles.
    Smith MA; Sayre LM; Monnier VM; Perry G
    Mol Chem Neuropathol; 1996; 28(1-3):41-8. PubMed ID: 8871940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress.
    Praprotnik D; Smith MA; Richey PL; Vinters HV; Perry G
    Acta Neuropathol; 1996; 91(1):1-5. PubMed ID: 8773139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
    Siedlak SL; Jiang Y; Huntley ML; Wang L; Gao J; Xie F; Liu J; Su B; Perry G; Wang X
    J Alzheimers Dis; 2017; 58(4):1027-1033. PubMed ID: 28527219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The axonal origin of a subpopulation of dystrophic neurites in Alzheimer's disease.
    Tourtellotte WG; Van Hoesen GW
    Neurosci Lett; 1991 Aug; 129(1):11-6. PubMed ID: 1922959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in Alzheimer's disease].
    Morishima-Kawashima M; Ihara Y
    Seikagaku; 2001 Nov; 73(11):1297-307. PubMed ID: 11831025
    [No Abstract]   [Full Text] [Related]  

  • 12. Dystrophic neurites infiltrate extracellular neurofibrillary tangles in Alzheimer disease.
    Vande Weghe J; Cras P; Kawai M; Siedlak SL; Tabaton M; Greenberg B; Perry G
    Brain Res; 1991 Sep; 560(1-2):303-5. PubMed ID: 1760735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
    Yilmazer-Hanke DM
    Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of neurofibrillary tangles in Alzheimer disease.
    Brion JP
    Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue kallikrein-like immunoreactive material decorates neuritic plaques of Alzheimer patients.
    Bernstein HG
    Clin Neuropathol; 1997; 16(2):69-71. PubMed ID: 9101107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human striatum: the distribution of neurofibrillary tangles in Alzheimer's disease.
    Selden N; Mesulam MM; Geula C
    Brain Res; 1994 Jun; 648(2):327-31. PubMed ID: 7922549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neurofibrillary tangles: implications for MAP kinase activation in Alzheimer disease.
    Knowles RB; Chin J; Ruff CT; Hyman BT
    J Neuropathol Exp Neurol; 1999 Oct; 58(10):1090-8. PubMed ID: 10515232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calsyntenin-3 C-terminal fragment accumulates in dystrophic neurites surrounding aβ plaques in tg2576 mouse and Alzheimer disease brains: its neurotoxic role in mediating dystrophic neurite formation.
    Uchida Y; Gomi F; Murayama S; Takahashi H
    Am J Pathol; 2013 May; 182(5):1718-26. PubMed ID: 23499467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it time to reassess the pathological criteria for a diagnosis of Alzheimer disease?
    Miller DC
    Alzheimer Dis Assoc Disord; 1993; 7(3):129-31. PubMed ID: 8217086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.